FDA actions, GLP-1 access fight and an AI drug safety push.

January 21, 2026

1. Compounding pharmacy sues Eli Lilly, Novo Nordisk over GLP-1 access Full story

2. FDA fast-tracks novel Parkinson's cell therapy Full story

3. Drug shortages are daily threats. UVA Health shows their strategies to restore control here

 

4. Congress pitches bipartisan health package: 8 things to know Full story

5. FDA delays 2 drug reviews in priority voucher program Full story

6. St. Jude, WellSpan leaders talk AI adoption, governance + trust in imaging — here.

 

7. FDA proposes new endpoints for multiple myeloma drug trials Full story

8. Cedars-Sinai to build drug safety AI tool Full story

Becker's Learning Opportunities

9. Margins, power brokers & site-of-care shifts — Get experts' take on 2026's big trends here.

10. How are peers making purchasing calls ahead of 2026? Benchmark your strategy here.

11. 3-week waits signal risk. Use this 90-day automation framework to shorten access delays here.

12. Interested in more? See Becker's full lineup of webinars

 

 

Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by a provider organization.

 

 

Contact Us, Feedback, or Questions – Email ldyrda@beckershealthcare.com

Manage Preferences     Unsubscribe     Forward to a friend    Contact Us     

Privacy Policy     

 

View our profile on LinkedIn Follow us on Twitter Follow us on Facebook Check out our YouTube Channel    

17 N. State, Suite 1800 | Chicago, IL 60602
Becker's Hospital Review, A Becker's Healthcare Publication